Weight-loss drug approved to reduce risk of non-fatal heart attacks | Canada Tonight [mbSH2ltCKXT]

Weight-loss drug approved to reduce risk of non-fatal heart attacks | Canada Tonight [mbSH2ltCKXT]

| 1h 28m 28s | Video has closed captioning.

Health Canada has approved the weight-loss drug Wegovy to reduce the risk of non-fatal heart attacks, drug maker Novo Nordisk says. But how does it work? Dr. Samir Gupta discusses Health Canada's decision. Read more: »»» Subscribe to CBC News to watch more videos: Connect with CBC News Online: For breaking news, video, audio and in-depth coverage: Follow CBC News on TikTok: Follow CBC News on Twitter: Find CBC News on Facebook: Follow CBC News on Instagram: Subscribe to CBC News on Snapchat: Download the CBC News app for iOS: Download the CBC News app for Android: »»»»»»»»»»»»»»»»»» For more than 80 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians. #keto gummies diarrhea #gold diet pills #does gnc have keto acv gummies #shark tanks x10 boost keto acv